![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PLEKHH1 |
Gene summary for PLEKHH1 |
![]() |
Gene information | Species | Human | Gene symbol | PLEKHH1 | Gene ID | 57475 |
Gene name | pleckstrin homology, MyTH4 and FERM domain containing H1 | |
Gene Alias | PLEKHH1 | |
Cytomap | 14q24.1 | |
Gene Type | protein-coding | GO ID | GO:0005575 | UniProtAcc | Q9ULM0 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
57475 | PLEKHH1 | Adj_PTCwithHT_6 | Human | Thyroid | HT | 1.21e-04 | -2.47e-01 | 0.02 |
57475 | PLEKHH1 | PTCwithHT_6 | Human | Thyroid | HT | 3.99e-02 | -2.45e-01 | 0.02 |
57475 | PLEKHH1 | PTCwithHT_8 | Human | Thyroid | HT | 2.56e-04 | -2.34e-01 | 0.0351 |
57475 | PLEKHH1 | PTCwithoutHT_2 | Human | Thyroid | PTC | 9.60e-03 | -2.33e-01 | 0.0419 |
57475 | PLEKHH1 | male-WTA | Human | Thyroid | PTC | 2.11e-29 | 1.78e-01 | 0.1037 |
57475 | PLEKHH1 | PTC01 | Human | Thyroid | PTC | 4.18e-08 | -3.01e-02 | 0.1899 |
57475 | PLEKHH1 | PTC03 | Human | Thyroid | PTC | 5.00e-09 | 2.99e-01 | 0.1784 |
57475 | PLEKHH1 | PTC04 | Human | Thyroid | PTC | 2.41e-19 | 2.18e-01 | 0.1927 |
57475 | PLEKHH1 | PTC05 | Human | Thyroid | PTC | 1.01e-12 | 4.51e-01 | 0.2065 |
57475 | PLEKHH1 | PTC06 | Human | Thyroid | PTC | 2.50e-27 | 6.79e-01 | 0.2057 |
57475 | PLEKHH1 | PTC07 | Human | Thyroid | PTC | 1.39e-33 | 4.37e-01 | 0.2044 |
57475 | PLEKHH1 | ATC12 | Human | Thyroid | ATC | 4.26e-04 | -2.42e-01 | 0.34 |
57475 | PLEKHH1 | ATC13 | Human | Thyroid | ATC | 7.21e-04 | -2.39e-01 | 0.34 |
57475 | PLEKHH1 | ATC4 | Human | Thyroid | ATC | 9.68e-04 | -2.41e-01 | 0.34 |
57475 | PLEKHH1 | ATC5 | Human | Thyroid | ATC | 1.72e-03 | -2.38e-01 | 0.34 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Thyroid | ![]() | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis | ||
PTC: Papillary thyroid cancer |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PLEKHH1 | SNV | Missense_Mutation | rs758910064 | c.2936G>A | p.Arg979His | p.R979H | Q9ULM0 | protein_coding | deleterious(0.03) | benign(0.083) | TCGA-B5-A3FC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
PLEKHH1 | SNV | Missense_Mutation | novel | c.3248G>A | p.Gly1083Asp | p.G1083D | Q9ULM0 | protein_coding | deleterious(0.03) | benign(0.313) | TCGA-BG-A222-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
PLEKHH1 | SNV | Missense_Mutation | c.2296N>G | p.Ile766Val | p.I766V | Q9ULM0 | protein_coding | tolerated(0.31) | benign(0.047) | TCGA-BS-A0UJ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
PLEKHH1 | SNV | Missense_Mutation | novel | c.1116N>T | p.Glu372Asp | p.E372D | Q9ULM0 | protein_coding | tolerated(0.55) | benign(0) | TCGA-DF-A2KN-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
PLEKHH1 | SNV | Missense_Mutation | novel | c.606N>T | p.Gln202His | p.Q202H | Q9ULM0 | protein_coding | tolerated_low_confidence(0.07) | benign(0.275) | TCGA-DF-A2KU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
PLEKHH1 | SNV | Missense_Mutation | novel | c.2413N>A | p.Ala805Thr | p.A805T | Q9ULM0 | protein_coding | tolerated(0.06) | benign(0.03) | TCGA-DF-A2KU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
PLEKHH1 | SNV | Missense_Mutation | novel | c.4003A>G | p.Asn1335Asp | p.N1335D | Q9ULM0 | protein_coding | tolerated(0.63) | benign(0) | TCGA-DF-A2KV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
PLEKHH1 | SNV | Missense_Mutation | novel | c.809N>C | p.Met270Thr | p.M270T | Q9ULM0 | protein_coding | tolerated_low_confidence(0.43) | benign(0.003) | TCGA-EC-A1NJ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
PLEKHH1 | SNV | Missense_Mutation | novel | c.2953A>G | p.Ile985Val | p.I985V | Q9ULM0 | protein_coding | tolerated(0.06) | benign(0.193) | TCGA-EC-A1QX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Chemotherapy | cyclophosphamide | PD |
PLEKHH1 | SNV | Missense_Mutation | novel | c.3595A>G | p.Lys1199Glu | p.K1199E | Q9ULM0 | protein_coding | deleterious(0) | benign(0.219) | TCGA-EC-A1QX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Chemotherapy | cyclophosphamide | PD |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |